Symptomatic interferon retinopathy successfully treated by hypertension management [4]

British Journal of Ophthalmology

Volumn 91, Issue 9, 2007, Pages 1250-1251

  Han, C ^a   O'Day, J ^b  

^a ST VINCENT S HOSPITAL   (Australia)

^b ROYAL VICTORIAN EYE AND EAR HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; ANTIHYPERTENSIVE AGENT; BEVACIZUMAB;

ADULT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; EYE EXAMINATION; FLUORESCENCE ANGIOGRAPHY; HUMAN; LETTER; MALE; OPHTHALMOSCOPY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RADIODIAGNOSIS; RETINOPATHY;

ANTIHYPERTENSIVE AGENTS; ANTINEOPLASTIC AGENTS; HUMANS; HYPERTENSION; INTERFERON ALFA-2A; LUNG NEOPLASMS; MALE; MIDDLE AGED; RETINAL DISEASES;

EID: 34548301265     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2006.112532     Document Type: Letter

References (6)

1. d'Alteroche L, Majzoub S, Lecuyer A, et al. Ophthalmologic side effects during alpha-interferon therapy for viral hepatitis. J Hepatol 2006;44:56-61.
2. Hejny C, Sternberg P, Lawson DH, et al. Retinopathy associated with high-dose interferon alfa-2b therapy. Am J Ophthalmol 2001;131:782-7.
3. Guyer DR, Tiedeman J, Yannuzzi LA, et al. Interferon-associated retinopathy. Arch Ophthalmol 1993;111:350-6.
4. Saito H, Ebinuma H, Nagata H, et al. Interferon-associated retinopathy in a uniform regimen of natural interferon-alpha therapy for chronic hepatitis C. Liver 2001;21:192-7.
5. Kaiser WJ, Kaufman JL, Offermann MK. IFN-alpha sensitizes human umbilical vein endothelial cells to apoptosis induced by double-stranded RNA. J Immunol 2004;172:1699-710.
6. Kawano T, Shigehira M, Uto H, et al. Retinal complications during interferon therapy for chronic hepatitis C. Am J Gastroenterol 1996;91:309-13.